You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone sensitive

Showing 1 - 25 of 9,154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Learn More About How Safe Darolutamide is Under Real-world

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
  • No Intervention
  • Multiple Locations, Japan
    Many Locations
Aug 24, 2023

Apalutamide in Metastatic Hormone Sensitive Prostate Cancer

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Cardiff, United Kingdom
    • +4 more
    Aug 25, 2023

    High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate

    Not yet recruiting
    • High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
    • dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
    • placebo; abiraterone acetate tablets; prednisone tablets
    • (no location specified)
    Oct 20, 2023

    Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)

    Recruiting
    • Metastatic Prostate Cancer
    • +2 more
    • Nanjing, Jiangsu, China
      Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
    Aug 2, 2023

    Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Jun 14, 2023

    Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

    Not yet recruiting
    • Oligometastatic Hormone Sensitive Prostate Cancer
    • SBRT on all sites of metastatic disease+Apalutamide
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jan 29, 2023

    Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,

    Recruiting
    • Prostate Cancer
    • +2 more
    • Moderate hypo-fractionation
    • Ultra-hypo-fractionation
    • Umeå, Sweden
      Cancercenter University hospital of Umeå
    Nov 1, 2022

    Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

    Recruiting
    • Hormone Sensitive Metastatic Prostate Cancer
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Jul 13, 2022

    Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

    Completed
    • Metastatic Hormone-Sensitive Prostate Cancer
    • PROSTVAC-V
    • +9 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 3, 2022

    Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Weill Cornell Medicine - New York Presbyterian Hospital
    Oct 3, 2022

    Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

    Recruiting
    • Metastatic Hormone Refractory Prostate Cancer
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 6, 2022

    Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

    Not yet recruiting
    • Prostate Cancer
    • Chicago, Illinois
      Northwestern University
    Sep 27, 2023

    Hormone Sensitive Prostate Cancer Trial in Qingdao (SHR7280)

    Recruiting
    • Hormone Sensitive Prostate Cancer
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    Jan 13, 2022

    Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

    Recruiting
    • Metastatic Hormone-sensitive Prostate Cancer
    • Darolutamide (BAY1841788, Nubeqa)
    • ADT
    • Homewood, Alabama
    • +11 more
    Jan 13, 2023

    Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

    Recruiting
    • Prostate Cancer Metastatic
    • +2 more
    • stereotactic body radiotherapy
    • +2 more
    • Umeå, Umea, Sweden
    • +1 more
    May 19, 2022

    Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))

    Active, not recruiting
    • Metastatic Hormone Sensitive Prostate Cancer
    • Beijing, China
    • +29 more
    Jan 7, 2023

    Based Discrete Choice Experiment Study in Prostate Cancer Study

    Completed
    • Prostate Cancer
    • Metastatic Hormone-sensitive Prostate Cancer
      • Durham, North Carolina
        Duke Clinical Research Institute
      Jan 10, 2023

      Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

      Recruiting
      • Prostate Cancer Metastatic
      • New York, New York
        Columbia University Irving Medical Center
      Mar 22, 2022

      Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

      Not yet recruiting
      • Prostate Cancer
      • PSMA-PET/CT response evaluation
      • Utrecht, Netherlands
        Roderick van den Bergh
      Sep 10, 2022

      Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

      Recruiting
      • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
      • 6-month course of antiandrogen drugs
      • Long-term course of antiandrogen drugs
      • Nanjing, Jiangsu, China
        Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
      Jul 13, 2023

      New Healthcare Approach Trial in Munich (Intervention)

      Not yet recruiting
      • New Healthcare Approach
      • Intervention
      • Munich, Germany
        Klinikum rechts der Isar, Frauenklinik, Technische Universität M
      Aug 12, 2022

      Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction Trial in Guangzhou (SHR7280

      Not yet recruiting
      • Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
      • SHR7280 tablets
      • SHR7280 dry suspension
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      May 11, 2023

      Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

      Active, not recruiting
      • Prostate Cancer
      • Prostate Adenocarcinoma
      • Charlotte, North Carolina
        Levine Cancer Institute
      Jan 12, 2023

      Prostate Cancer Trial in Amsterdam, Groningen, Nijmegen (177Lu-PSMA-617)

      Recruiting
      • Prostate Cancer
      • Amsterdam, Netherlands
      • +3 more
      Oct 17, 2021